Clinical Trial Update: This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy of difamilast ointment in patients with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Difamilast ointment (difamilast)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED